Certified by Founder
Lodge
SpyGlass Pharma, Inc.
start up
United States
- Aliso Viejo, California
- 11/07/2023
- Series C
- $90,000,000
SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. The company is focused on the development of novel treatments for chronic ophthalmic diseases based on technology originally developed in the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine.
- Industry Pharmaceutical Manufacturing
- Website https://www.spyglasspharma.com/
- LinkedIn https://www.linkedin.com/company/spyglasspharma/
Related People
Patrick MooneyFounder
United States -
Southlake, Texas
Experienced Leader with a demonstrated history of success in the pharmaceuticals industry. Skilled in Pharmaceutics, Medical Devices, Operations, Management and People Development.
Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Ranger AI | $8,400,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
GridCARE | $64,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)